1. Home
  2. KYMR vs CRUS Comparison

KYMR vs CRUS Comparison

Compare KYMR & CRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$69.69

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Logo Cirrus Logic Inc.

CRUS

Cirrus Logic Inc.

HOLD

Current Price

$123.27

Market Cap

5.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KYMR
CRUS
Founded
2015
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
5.9B
IPO Year
2020
1989

Fundamental Metrics

Financial Performance
Metric
KYMR
CRUS
Price
$69.69
$123.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
24
5
Target Price
$105.35
$140.00
AVG Volume (30 Days)
743.7K
412.8K
Earning Date
02-26-2026
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
19.23
EPS
N/A
7.02
Revenue
$43,735,000.00
$1,948,426,000.00
Revenue This Year
$18.70
$1.21
Revenue Next Year
N/A
$2.40
P/E Ratio
N/A
$17.54
Revenue Growth
N/A
2.19
52 Week Low
$19.45
$75.83
52 Week High
$103.00
$136.92

Technical Indicators

Market Signals
Indicator
KYMR
CRUS
Relative Strength Index (RSI) 39.39 54.38
Support Level $71.46 $122.15
Resistance Level $76.71 $128.00
Average True Range (ATR) 3.72 3.62
MACD -1.19 0.38
Stochastic Oscillator 4.32 62.39

Price Performance

Historical Comparison
KYMR
CRUS

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About CRUS Cirrus Logic Inc.

Cirrus Logic Inc is a provider of integrated circuits for audio and voice signal processing applications. The firm's products are organized into two streams: portable audio products, and HPMS Products. These products include aAmplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, Europe, South Korea, and countries across the world.

Share on Social Networks: